Stocktoria
Travere Therapeutics, Inc. TVTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2003-07-23
Travere Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,644,789 | $62.8M | 8.41% |
| RENAISSANCE TECHNOLOGIES LLC | 1,966,779 | $58.4M | 2.16% |
| TWO SIGMA INVESTMENTS, LP | 1,508,259 | $44.8M | 1.66% |
| D. E. Shaw & Co., Inc. | 836,544 | $24.9M | 0.92% |
| CITADEL ADVISORS LLC | 480,664 | $14.3M | 0.53% |
| AQR CAPITAL MANAGEMENT LLC | 305,412 | $9.1M | 0.34% |
| MILLENNIUM MANAGEMENT LLC | 20,000 | $594,200 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.